2 research outputs found
Link Mining for Kernel-based Compound-Protein Interaction Predictions Using a Chemogenomics Approach
Virtual screening (VS) is widely used during computational drug discovery to
reduce costs. Chemogenomics-based virtual screening (CGBVS) can be used to
predict new compound-protein interactions (CPIs) from known CPI network data
using several methods, including machine learning and data mining. Although
CGBVS facilitates highly efficient and accurate CPI prediction, it has poor
performance for prediction of new compounds for which CPIs are unknown. The
pairwise kernel method (PKM) is a state-of-the-art CGBVS method and shows high
accuracy for prediction of new compounds. In this study, on the basis of link
mining, we improved the PKM by combining link indicator kernel (LIK) and
chemical similarity and evaluated the accuracy of these methods. The proposed
method obtained an average area under the precision-recall curve (AUPR) value
of 0.562, which was higher than that achieved by the conventional Gaussian
interaction profile (GIP) method (0.425), and the calculation time was only
increased by a few percent
Drug Target Interaction Prediction Using Machine Learning Techniques – A Review
Drug discovery is a key process, given the rising and ubiquitous demand for medication to stay in good shape right through the course of one’s life. Drugs are small molecules that inhibit or activate the function of a protein, offering patients a host of therapeutic benefits. Drug design is the inventive process of finding new medication, based on targets or proteins. Identifying new drugs is a process that involves time and money. This is where computer-aided drug design helps cut time and costs. Drug design needs drug targets that are a protein and a drug compound, with which the interaction between a drug and a target is established. Interaction, in this context, refers to the process of discovering protein binding sites, which are protein pockets that bind with drugs. Pockets are regions on a protein macromolecule that bind to drug molecules. Researchers have been at work trying to determine new Drug Target Interactions (DTI) that predict whether or not a given drug molecule will bind to a target. Machine learning (ML) techniques help establish the interaction between drugs and their targets, using computer-aided drug design. This paper aims to explore ML techniques better for DTI prediction and boost future research. Qualitative and quantitative analyses of ML techniques show that several have been applied to predict DTIs, employing a range of classifiers. Though DTI prediction improves with negative drug target pairs (DTP), the lack of true negative DTPs has led to the use a particular dataset of drugs and targets. Using dynamic DTPs improves DTI prediction. Little attention has so far been paid to developing a new classifier for DTI classification, and there is, unquestionably, a need for better ones